Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why First Solar, Veracyte, and KB Home Jumped Today

Most investors believed that the Federal Open Market Committee's meeting today would prove to be a non-event. But while the continuation of the Fed taper didn't surprise anyone, Fed Chair Janet Yellen's comments during the subsequent press conference threw markets for a loop, with hints that the Fed could raise interest rates sooner after the end of quantitative easing than investors had expected. That send the Dow down triple digits, but it didn't stop solid advances for First Solar (NASDAQ: FSLR  ) , Veracyte (NASDAQ: VCYT  ) , or KB Home (NYSE: KBH  ) .

First Solar soared more than 20% after the solar giant gave positive guidance for revenue during the current year and for better profits in 2015 and 2016 than investors were expecting. Interestingly, First Solar's revenue guidance doesn't call for guaranteed fast growth, with ranges of $3.7 billion to $4 billion this year, $3.8 billion to $4.3 billion in 2015, and $3.8 billion to $4.5 billion in 2016. But even though some analysts have argued that First Solar's operating expenses could keep profit margins down and hold back earnings growth, First Solar's projections for earnings to rise to as much as $5 per share by 2016 are quite optimistic compared to the consensus of analysts. With so much competition in the solar industry and with First Solar largely shut out of the fast-growing residential-solar segment, the company will need to see favorable trends continue in order to reach its lofty goals.

Veracyte climbed 8%, as the biotech diagnostics company released earnings last night. Revenue climbed 53% from year ago levels, with its Afirma Thyroid FNA Analysts and Afirma Gene Expression Classifier products gaining traction in the diagnostics marketplace. Specifically, as Veracyte has gotten more health insurance companies to provide coverage for expenses related to its products, it has seen greater adoption of those products among physicians. Still, with the company having jumped more than 40% since its first-day close after its October 2013 IPO, Veracyte still has a lot of growing to do before it can convince some skeptical investors that it has staying power in the highly competitive health-care niche. But with revenue guidance for 2014 that could almost double 2013's figures, Veracyte's growth potential is extensive.

KB Home rose almost 6% after this morning's earnings report from the homebuilder defied some forecasts for a weak season. KB Home reversed a year-ago loss with a profit of $0.12 per share, which is unusual for this particular season of the year, as revenue jumped 11% on an 18% rise in net orders and 21% gains in backlogs. Tight markets for available land have sent average home prices soaring, with KB Home reporting averages of more than $305,000, up 12% from last year's levels. The good news pulled peer Lennar (NYSE: LEN  ) up as well, and with Lennar reporting its earnings tomorrow, investors should soon see whether KB Home's positive results were a fluke or an indication of widespread strength in housing.

Get rich from just one stock?
Opportunities to get wealthy from a single investment don't come around often, but they do exist, and our chief technology officer believes he's found one. In this free report, Jeremy Phillips shares the single company that he believes could transform not only your portfolio, but also your entire life. To learn the identity of this stock for free and see why Jeremy is putting more than $100,000 of his own money into it, all you have to do is click here now.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2882634, ~/Articles/ArticleHandler.aspx, 9/1/2015 12:20:06 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Caplinger

Dan Caplinger has been a contract writer for the Motley Fool since 2006. As the Fool's Director of Investment Planning, Dan oversees much of the personal-finance and investment-planning content published daily on With a background as an estate-planning attorney and independent financial consultant, Dan's articles are based on more than 20 years of experience from all angles of the financial world.

Today's Market

updated 3 hours ago Sponsored by:
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASD 4,776.51 -51.82 -1.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/31/2015 3:59 PM
FSLR $47.84 Up +0.04 +0.08%
First Solar CAPS Rating: ***
KBH $14.65 Up +0.22 +1.52%
KB Home CAPS Rating: **
LEN $50.90 Up +0.47 +0.93%
Lennar Corp CAPS Rating: ***
VCYT $9.43 Up +0.69 +7.89%
Veracyte CAPS Rating: No stars